Orchestra BioMed raised $110 million; COVID cases surge; California to make its own insulin
Top Health News Drugmaker Sanofi launched Impact, a new brand of standard of care medicines dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries. The Impac brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover a … [Read more]